[HTML][HTML] α 干扰素在白塞综合征中的应用进展

严冬, 郑文洁 - Journal of Peking University (Health Sciences), 2020 - ncbi.nlm.nih.gov
!! 白塞综合征(^ 8? D8> 3F4: 76@ 8,^ J) 是一种慢性复发性自身免疫性疾病,
其病理基础为血管炎, 可累及多脏器, 如皮肤, 黏膜, 关节, 眼, 还可累及心脏大血管 …

Biological therapies that target inflammatory cytokines to treat uveitis

A Reddy, F Muhammad, DJ Lee - Advances in the Diagnosis and …, 2018 - books.google.com
Uveitis is a leading cause of blindness that presents a considerable challenge given that our
understanding of the mechanisms of disease is still evolving. Both innate and adaptive …

[HTML][HTML] Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography

V Albano, S Guerriero, C Furino, G Sborgia… - International …, 2022 - Springer
Background Posterior uveitis represents the second most frequent type of uveitis (15–30% of
all uveitis). Noninfectious posterior uveitis complicated with secondary cystoid macular …

[PDF][PDF] 解读欧洲抗风湿病联盟关于白塞葡萄膜炎治疗的最新建议

赵潺, 张美芬 - 中华眼科医学杂志(电子版), 2018 - medi-guide.meditool.cn
白塞葡萄膜炎是国人最为常见的后葡萄膜炎或全葡萄膜炎类型之一, 其临床预后较差,
致盲率较高, 是葡萄膜炎领域的挑战之一. 白塞葡萄膜炎的治疗方法主要包括糖皮质激素 …

Behçet uveitis: Current practice and future perspectives

L Hassan, R El Zanaty, M Refaat, R Amin… - Frontiers in …, 2022 - europepmc.org
Described as early as Hippocrates in his “Third Book of Endemic Diseases,” Behçet's
Disease (BD), also known as “The Silk Road Disease” following its initial demographics …

An Overview of Conventional and Recent Treatment Options for Behcet's Disease

K Cetin Gedik, M Romano, RA Berard… - … Treatment Options in …, 2020 - Springer
Purpose of review Behcet's disease (BD) is a multi-system inflammatory disorder
characterized by a relapsing–remitting course. Several treatment modalities with different …

Disease Management

V Hamuryudan, I Kötter, H Tüzün - Behçet Syndrome, 2020 - Springer
The aim of treatment is suppression of symptoms and prevention of organ damage.
Immunosuppressives constitute the mainstay of treatment. Male sex, young age, and short …

[PDF][PDF] Behçet's disease: A Narrative Review of Clinical Diagnosis and Treatment

G Aktas, A Khalid, H Akın, SB Balci… - Northwestern …, 2021 - jag.journalagent.com
Behçet's disease is characterized with recurrent attacks of inflammation that are driven by
systemic vasculitis without any clearly demonstrated triggering mechanism. It is more …

[PDF][PDF] The role of biosimilars in uveitis: long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors. Front Pharmacol 10: 1468

C Fabiani, A Vitale, G Emmi, A Sgheri, G Lopalco… - 2019 - academia.edu
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to
the employment of biosimilars in clinical practice. The aim of the study was to identify any …

Utilidade dos fármacos biotecnológicos nas diferentes manifestações clínicas da Doença de Behçet–revisão sistemática

SSAD Carvalho - ubibliorum.ubi.pt
Introdução: a Doença de Behçet (DB) corresponde a uma vasculite de envolvimento
multissistémico cuja variabilidade demográfica, clínica, terapêutica e prognóstica, a tornam …